Feifan Yao

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Jiangsu Province Hospital, Nanjing Medical University · ORCID：0000-0002-6060-6528

发表论文 4 篇 · 总被引 195 次 · h-index 3

代表论文

• Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma (2023 · Journal of Hepatology · 被引 156)
• Etomidate elicits anti-tumor capacity by disrupting the JAK2/STAT3 signaling pathway in hepatocellular carcinoma (2022 · Cancer Letters · 被引 26)
• Hepatocyte Deubiquitinating Enzyme OTUD5 Deficiency is a Key Aggravator for Metabolic Dysfunction-Associated Steatohepatitis by Disturbing Mitochondrial Homeostasis (2023 · Cellular and Molecular Gastroenterology and Hepatology · 被引 11)
• Ciprofol exerts anti-tumour effects in hepatocellular carcinoma through the Raf-MEK-ERK signalling pathway (2025 · Translational Gastroenterology and Hepatology · 被引 2)